Annie Haase1, Anne C Goldberg. 1. Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Abstract
PURPOSE OF REVIEW: Familial hypercholesterolemia is an underdiagnosed autosomal codominant genetic condition associated with significantly increased risk of early cardiovascular disease when untreated. Early diagnosis and treatment decrease the excess risk, and strategies for identification of affected individuals are being developed worldwide. This review will discuss, from a clinician's perspective, some of the issues involved in identifying people with familial hypercholesterolemia. RECENT FINDINGS: Several sets of recommendations have been published outlining the strategies for identification of people with familial hypercholesterolemia in various countries and regions. These include Australasia, Europe, and the USA. SUMMARY: Continuing efforts to find the best methods for identification of people with familial hypercholesterolemia are needed to ensure that this very treatable inherited condition is diagnosed early enough to prevent the development of atherosclerotic vascular disease.
PURPOSE OF REVIEW: Familial hypercholesterolemia is an underdiagnosed autosomal codominant genetic condition associated with significantly increased risk of early cardiovascular disease when untreated. Early diagnosis and treatment decrease the excess risk, and strategies for identification of affected individuals are being developed worldwide. This review will discuss, from a clinician's perspective, some of the issues involved in identifying people with familial hypercholesterolemia. RECENT FINDINGS: Several sets of recommendations have been published outlining the strategies for identification of people with familial hypercholesterolemia in various countries and regions. These include Australasia, Europe, and the USA. SUMMARY: Continuing efforts to find the best methods for identification of people with familial hypercholesterolemia are needed to ensure that this very treatable inherited condition is diagnosed early enough to prevent the development of atherosclerotic vascular disease.
Authors: Joshua W Knowles; Emily C O'Brien; Karen Greendale; Katherine Wilemon; Jacques Genest; Laurence S Sperling; William A Neal; Daniel J Rader; Muin J Khoury Journal: Am Heart J Date: 2014-09-16 Impact factor: 4.749
Authors: Joseph B Dubé; Jian Wang; Henian Cao; Adam D McIntyre; Christopher T Johansen; Scarlett E Hopkins; Randa Stringer; Siyavash Hosseinzadeh; Brooke A Kennedy; Matthew R Ban; T Kue Young; Philip W Connelly; Eric Dewailly; Peter Bjerregaard; Bert B Boyer; Robert A Hegele Journal: Circ Cardiovasc Genet Date: 2014-11-20
Authors: Nadeem Qureshi; Maria Luisa R Da Silva; Hasidah Abdul-Hamid; Stephen F Weng; Joe Kai; Jo Leonardi-Bee Journal: Cochrane Database Syst Rev Date: 2021-10-07
Authors: Aitor Etxebarria; Asier Benito-Vicente; Ana C Alves; Helena Ostolaza; Mafalda Bourbon; Cesar Martin Journal: PLoS One Date: 2014-11-11 Impact factor: 3.240
Authors: Harold E Bays; Pam R Taub; Elizabeth Epstein; Erin D Michos; Richard A Ferraro; Alison L Bailey; Heval M Kelli; Keith C Ferdinand; Melvin R Echols; Howard Weintraub; John Bostrom; Heather M Johnson; Kara K Hoppe; Michael D Shapiro; Charles A German; Salim S Virani; Aliza Hussain; Christie M Ballantyne; Ali M Agha; Peter P Toth Journal: Am J Prev Cardiol Date: 2021-01-23